Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication

Review Series

Angiogenesis

Series edited by David Cheresh

Therapeutic manipulation of angiogenesis would be desirable for the treatment of a variety of diseases, including cancer and heart disease. This short series focuses this therapeutic potential and specifically on integrins and matrix metalloproteinases as potential targets.

Articles in series

The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development
Brian P. Eliceiri, David A. Cheresh
Brian P. Eliceiri, David A. Cheresh
Published May 1, 1999
Citation Information: J Clin Invest. 1999;103(9):1227-1230. https://doi.org/10.1172/JCI6869.
View: Text | PDF

The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development

  • Text
  • PDF
Abstract

Authors

Brian P. Eliceiri, David A. Cheresh

×

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
Jeffrey M. Isner, Takayuki Asahara
Jeffrey M. Isner, Takayuki Asahara
Published May 1, 1999
Citation Information: J Clin Invest. 1999;103(9):1231-1236. https://doi.org/10.1172/JCI6889.
View: Text | PDF

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

  • Text
  • PDF
Abstract

Authors

Jeffrey M. Isner, Takayuki Asahara

×

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
William G. Stetler-Stevenson
William G. Stetler-Stevenson
Published May 1, 1999
Citation Information: J Clin Invest. 1999;103(9):1237-1241. https://doi.org/10.1172/JCI6870.
View: Text | PDF

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention

  • Text
  • PDF
Abstract

Authors

William G. Stetler-Stevenson

×

Advertisement
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts